ONSOLIS

Type: Product
Name: ONSOLIS
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Breakthrough Pain: The Final Frontier

Each patient’s breakthrough pain has a unique mix of clinical features, just as each patient’s clinical experience of chronic pain differs. The health care profession has made tremendous strides in pain management in the past 20 years. Patients today ... [Published Pharmacy Times - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Biotech Stock Directory Update

(Investorideas.com Newswire) Investorideas.com staff: Investorideas.com, a global news source covering leading sectors issues the updated biotech stock directory for August.The directory is part of the member's directory list including tech and water ... [Published InvestorIdeas.com - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA

Related Stocks FE - Firstenergy CorpSym Last Chg Pct Volume FE32.41+0.06+0.19%3,333,300BDSI13.28-0.20-1.48%414,700 RALEIGH, N.C. , Aug. 12, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that along with its commercial ... [Published Barchart - Aug 12 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Meda and Valeant Terminates Joint Ventures

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates ... [Published Business Wire Health News - Apr 07 2014]

Quotes

...Andrew Finn , Executive Vice President of Product Development. "We will continue to work closely with our partner Endo Pharmaceuticals as they prepare the NDA submission for late this year or early next year."

More Content

All (5) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Breakthrough Pain: The Final Frontier [Published Pharmacy Times - Aug 15 2014]
Biotech Stock Directory Update [Published InvestorIdeas.com - Aug 14 2014]
BioDelivery Sciences Announces BEMA Buprenorphi... [Published Barchart - Aug 12 2014]
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
Meda and Valeant Terminates Joint Ventures [Published Business Wire Health News - Apr 07 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Meda and Valeant Terminates Joint Ventures [Published Business Wire Health News - Apr 07 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates ...
1

Press Releases

sort by: Date | Relevance
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.